The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Withaferin A inhibits breast cancer invasion and metastasis at sub‐cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation
Open accessAbstract
Withaferin A (WFA) is purified from the plant Withania somnifera and inhibits the vimentin cytoskeleton. Vimentin overexpression in cancer correlates with metastatic disease, induction of epithelial to mesenchymal transition and reduced patient survival. As vimentin functions in cell motility, we wanted to test the hypothesis that WFA inhibits cancer metastasis by disrupting vimentin function. These data showed that WFA had weak cytotoxic and apoptotic activity at concentrations less than or equal to 500 nM, but retained potent anti‐invasive activity at these low doses. Imaging of breast cancer cell lines revealed that WFA induces perinuclear vimentin accumulation followed by rapid vimentin depolymerization. A concomitant induction of vimentin ser56 phosphorylation was observed, which is consistent with vimentin disassembly. Structure activity relationships were established using a set of chemically modified WFA analogs and showed that the predicted vimentin‐binding region of WFA is necessary to induce vimentin ser56 phosphorylation and for its anti‐invasive activity. Pharmacokinetic studies in mice revealed that WFA reaches peak concentrations up to 2 μM in plasma with a half‐life of 1.36 hr following a single 4 mg/kg dose. In a breast cancer metastasis mouse model, WFA showed dose‐dependent inhibition of metastatic lung nodules and induced vimentin ser56 phosphorylation, with minimal toxicity to lung tissue. Based upon these studies, we conclude that WFA is a potent breast cancer anti‐metastatic agent and the anti‐metastatic activity of WFA is, at least in part, mediated through its effects on vimentin and vimentin ser56 phosphorylation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lahat, G., Zhu, Q.-S., Huang, K.-L., Wang, S., Bolshakov, S., Liu, J., Torres, K., Langley, R. R., Lazar, A. J., Hung, M. C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010105 · Cited by 213
RetractedEpithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Molecular requirements for epithelial–mesenchymal transition during tumor progression
Huber, M. A., Kraut, N., & Beug, H. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.08.001 · Cited by 1,821
INTERMEDIATE FILAMENTS: Structure, Dynamics, Function and Disease
Fuchs, E., & Weber, K. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.002021 · Cited by 1,411
Aslakson, C. J., & Miller, F. R. (1992) · PubMed · Cited by 1,234
Novel functions of vimentin in cell adhesion, migration, and signaling
Ivaska, J., Pallari, H.-M., Nevo, J., & Eriksson, J. E. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.03.040 · Cited by 785
Mice lacking vimentin develop and reproduce without an obvious phenotype
Colucci-Guyon, E., Portier, M.-M., Dunia, I., Paulin, D., Pournin, S., & Babinet, C. (1994) · Cell · doi:10.1016/0092-8674(94)90553-3 · Cited by 598
Impaired mechanical stability, migration and contractile capacity in vimentin deficient fibroblasts
Eckes, B., Dogic, D., Colucci-Guyon, E., Wang, N., Maniotis, A., Ingber, D., Merckling, A., Langa, F., Aumailley, M., Delouvée, A., et al. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.13.1897 · Cited by 483
Vimentin function in lymphocyte adhesion and transcellular migration
Nieminen, M., Henttinen, T., Merinen, M., Marttila–Ichihara, F., Eriksson, J. E., & Jalkanen, S. (2006) · Nature Cell Biology · doi:10.1038/ncb1355 · Cited by 460
Impaired wound healing in embryonic and adult mice lacking vimentin
Eckes, B., Guyon, E. C., Smola, H., Nodder, S., Babinet, C., Krieg, T., & Martin, P. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.13.2455 · Cited by 398
Kokkinos, M. I., Wafai, R., Wong, M. K., Newgreen, D. F., Thompson, E. W., & Waltham, M. (2007) · Cells Tissues Organs · doi:10.1159/000101320 · Cited by 394
Withaferin A is a potent inhibitor of angiogenesis
Mohan, R., Hammers, H., Bargagna-mohan, P., Zhan, X., Herbstritt, C., Ruiz, A., Zhang, L., Hanson, A., Conner, B., Rougas, J., et al. (2004) · Angiogenesis · doi:10.1007/s10456-004-1026-3 · Cited by 382
Bargagna-Mohan, P., Hamza, A., Kim, Y.-E., Khuan (Abby) Ho, Y., Mor-Vaknin, N., Wendschlag, N., Liu, J., Evans, R. M., Markovitz, D. M., Zhan, C.-G., et al. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.04.010 · Cited by 348
Eriksson, J. E., He, T., Trejo-Skalli, A. V., Härmälä-Braskén, A.-S., Hellman, J., Chou, Y.-H., & Goldman, R. D. (2004) · Journal of Cell Science · doi:10.1242/jcs.00906 · Cited by 336
Withaferin A targets heat shock protein 90 in pancreatic cancer cells
Yu, Y., Hamza, A., Zhang, T., Gu, M., Zou, P., Newman, B., Li, Y., Gunatilaka, A. A. L., Zhan, C.-G., & Sun, D. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.09.017 · Cited by 316
Vimentin contributes to human mammary epithelial cell migration
Gilles, C., Polette, M., Zahm, J.-M., Tournier, J.-M., Volders, L., Foidart, J.-M., & Birembaut, P. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.24.4615 · Cited by 314
Stan, S. D., Hahm, E.-R., Warin, R., & Singh, S. V. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1510 · Cited by 265
Tsuruta, D., & Jones, J. C. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00823 · Cited by 239
Par-4-Dependent Apoptosis by the Dietary Compound Withaferin A in Prostate Cancer Cells
Srinivasan, S., Ranga, R. S., Burikhanov, R., Han, S.-S., & Chendil, D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2430 · Cited by 230
Notch-1 Inhibition by Withaferin-A: A Therapeutic Target against Colon Carcinogenesis
Koduru, S., Kumar, R., Srinivasan, S., Evers, M. B., & Damodaran, C. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0771 · Cited by 215
Metastasis suppressors genes in cancer
Stafford, L. J., Vaidya, K. S., & Welch, D. R. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.12.016 · Cited by 175
Withanolides from Withania somnifera roots
Misra, L., Mishra, P., Pandey, A., Sangwan, R. S., Sangwan, N. S., & Tuli, R. (2008) · Phytochemistry · doi:10.1016/j.phytochem.2007.10.024 · Cited by 171
Marcus, A. I., Peters, U., Thomas, S. L., Garrett, S., Zelnak, A., Kapoor, T. M., & Giannakakou, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413471200 · Cited by 170
Self-citationStructure and Function of a Vimentin-associated Matrix Adhesion in Endothelial Cells
Gonzales, M., Weksler, B., Tsuruta, D., Goldman, R. D., Yoon, K. J., Hopkinson, S. B., Flitney, F. W., & Jones, J. C. R. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.1.85 · Cited by 158
Li, Q., Spinelli, A. M., Wang, R., Anfinogenova, Y., Singer, H. A., & Tang, D. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607715200 · Cited by 149
Chaurasiya, N. D., Uniyal, G. C., Lal, P., Misra, L., Sangwan, R. S., Tuli, R., & Sangwan, R. S. (2007) · Phytochemical Analysis · doi:10.1002/pca.1029 · Cited by 146
Actin microfilament aggregation induced by withaferin A is mediated by annexin II
Falsey, R. R., Marron, M. T., Gunaherath, G. M. K. B., et al. (2005) · Nature Chemical Biology · doi:10.1038/nchembio755 · Cited by 143
Kosako, H., Goto, H., Yanagida, M., Matsuzawa, K., Fujita, M., Tomono, Y., Okigaki, T., Odai, H., Kaibuchi, K., & Inagaki, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202633 · Cited by 118
Phosphorylation and reorganization of vimentin by p21‐activated kinase (PAK)
Goto, H., Tanabe, K., Manser, E. J., Lim, L., Yasui, Y., & Inagaki, M. (2002) · Genes to Cells · doi:10.1046/j.1356-9597.2001.00504.x · Cited by 118
Singh, D. K., Aggarwal, A., Maurya, R., & Naik, S. (2007) · Phytotherapy Research · doi:10.1002/ptr.2180 · Cited by 112
Tang, D. D., Bai, Y., & Gunst, S. J. (2005) · Biochemical Journal · doi:10.1042/bj20050065 · Cited by 109
Zhang, S., Schafer-Hales, K. J., Khuri, F. R., Zhou, W., Vertino, P. M., & Marcus, A. I. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2989 · Cited by 99
Self-citationDevelopment of the eye of the chick embryo.
Hilfer, S. R. (1983) · PubMed · Cited by 89
Bargagna-mohan, P., Paranthan, R. R., Hamza, A., Dimova, N., Trucchi, B., Srinivasan, C., Elliott, G. I., Zhan, C.-G., Lau, D., Zhu, H.-Y., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.093765 · Cited by 85
Chen, Y., Juan, H., Huang, H., Huang, H.-H., Lee, Y.-J., Liao, M.-Y., Tseng, C.-W., Lin, L., Chen, J.-Y., Wang, M.-J., et al. (2006) · Journal of Proteome Research · doi:10.1021/pr060212g · Cited by 76
Schafer-Hales, K. J., Iaconelli, J., Snyder, J. P., Prussia, A. J., Nettles, J. H., El‐Naggar, A. K., Khuri, F. R., Giannakakou, P., & Marcus, A. I. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0703 · Cited by 71
Self-citationMartys, J. L., Ho, C., Liem, R. K. H., & Gundersen, G. G. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.5.1289 · Cited by 67
Wu, M., Bai, X., Xu, G., Wei, J., Zhu, T., Zhang, Y., Li, Q., Liu, P., Song, A., Zhao, L., et al. (2007) · PROTEOMICS · doi:10.1002/pmic.200600643 · Cited by 58
Chen, M. H.-S., Yip, G. W. C., Tse, G. M.-K., Moriya, T., Lui, P. C. W., Zin, M.-L., Bay, B., & Tan, P. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.90 · Cited by 54
Fuska, J., Fusková, A., Rosazza, J. P. N., et al. (1984) · PubMed · Cited by 51
Does vimentin help to delineate the so-called 'basal type breast cancer'?
Kusińska, R., Kordek, R., Płuciennik, E., Bednarek, A. K., Piekarski, J. H., & Potemski, P. (2009) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-28-118 · Cited by 32
Cited by
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Shibue, T., & Weinberg, R. A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.44 · Cited by 2,539
Broad targeting of angiogenesis for cancer prevention and therapy
Wang, Z., Dabrosin, C., Yin, X., Fuster, M. M., Arreola, A., Rathmell, W. K., Generali, D., Nagaraju, G. P., El-Rayes, B., Ribatti, D., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.01.001 · Cited by 464
Pharmacologic overview of Withania somnifera, the Indian Ginseng
Dar, N. J., Hamid, A., & Ahmad, M. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2012-1 · Cited by 370
Targeting EMT in cancer: opportunities for pharmacological intervention
Davis, F. M., Stewart, T. A., Thompson, E. W., & Monteith, G. R. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.06.006 · Cited by 361
EMT Factors and Metabolic Pathways in Cancer
Georgakopoulos-Soares, I., Chartoumpekis, D. V., Kyriazopoulou, V., & Zaravinos, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00499 · Cited by 349
Metadata
- Authors
- Thaiparambil, J. T., Bender, L., Ganesh, T., Kline, E., Patel, P., Liu, Y., Tighiouart, M., Vertino, P. M., Harvey, R. D., Garcia, A., & Marcus, A. I.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2011-05-02
- Volume
- 129
- Issue
- 11
- Pages
- 2744-2755
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1992362205
- Cited by
- 289
- References
- 41
- FWCI
- 43.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.